Granules India Ltd.

₹517.95

Granules India Ltd.

₹517.95

₹517.95

1.75 (0.34%) - 24 May 2025 04:31 PM

About Company

Granules India Limited is one of the vertically integrated, high-growth pharmaceutical manufacturing company in India. Based out of Hyderabad, India, it is into manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediaries (PFIs) and Finished Dosages (FDs). The company’s product-focused, vertically integrated business model has created a leadership position in several generic drugs. It has a strong presence in ‘first line of defence’ products, including Paracetamol, Ibuprofen, Guaifenesin and Metformin.

Market Cap. ₹ 12,563 Cr.
52 Week - High/Low ₹ 721/401
P/E Ratio 38.91
P/B Ratio 4.04
Enterprise Value ₹ -102 Cr.
ROE % 15.08
RSI Value 66.11
EMA 50 488.55
EMA 200 516.18
Market Cap. ₹ 12,563 Cr.
52 Week - High/Low ₹ 721/401
P/E Ratio 26.20
P/B Ratio 3.89
Enterprise Value ₹ -210 Cr.
ROE % 13.46
RSI Value 66.11
EMA 50 488.55
EMA 200 516.18

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.